{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:39:03Z","timestamp":1791362343684,"version":"4.3.1"},"reference-count":25,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j. immunotherapy cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40425-019-0624-y","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T11:02:52Z","timestamp":1559905372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7843-615X","authenticated-orcid":false,"given":"Laura","family":"Marconato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Aresu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Stefanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Comazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Riondato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Rouquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Frayssinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sabattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,6,7]]},"reference":[{"issue":"3","key":"624_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/0300985810363902","volume":"47","author":"F Ponce","year":"2010","unstructured":"Ponce F, Marchal T, Magnol JP, Turinelli V, Ledieu D, Bonnefont C, Pastor M, Delignette ML, Fournel-Fleury C. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology. Vet Pathol. 2010;47(3):414\u201333.","journal-title":"Vet Pathol"},{"issue":"4","key":"624_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2460\/javma.238.4.480","volume":"238","author":"L Marconato","year":"2011","unstructured":"Marconato L, Stefanello D, Valenti P, Bonfanti U, Comazzi S, Roccabianca P, Caniatti M, Romanelli G, Massari F, Zini E. Predictors of long-term survival in dogs with high-grade multicentric lymphoma. J Am Vet Med Assoc. 2011;238(4):480\u20135.","journal-title":"J Am Vet Med Assoc"},{"issue":"11","key":"624_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111817","volume":"9","author":"A Aric\u00f2","year":"2014","unstructured":"Aric\u00f2 A, Ferraresso S, Bresolin S, Marconato L, Comazzi S, Te Kronnie G, Aresu L. Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma. PLoS One. 2014;9(11):e111817.","journal-title":"PLoS One"},{"issue":"6","key":"624_CR4","doi-asserted-by":"publisher","first-page":"e256","DOI":"10.3324\/haematol.2018.207027","volume":"104","author":"Luca Aresu","year":"2018","unstructured":"Aresu L, Ferraresso S, Marconato L, Cascione L, Napoli S, Gaudio E, Kwee I, Tarantelli C, Testa A, Maniaci C, et al. New molecular and therapeutic insights into canine diffuse large B cell lymphoma elucidates the role of the dog as a model for human disease. Haematologica. 2018 Dec 13. \n                    https:\/\/doi.org\/10.3324\/haematol.2018.207027\n                    \n                  .","journal-title":"Haematologica"},{"issue":"11","key":"624_CR5","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2217\/imt-2016-0080","volume":"8","author":"TU Marron","year":"2016","unstructured":"Marron TU, Ronner L, Martin PE, Flowers CR, Brody JD. Vaccine strategies for the treatment of lymphoma: preclinical progress and clinical trial update. Immunotherapy. 2016;8(11):1335\u201346.","journal-title":"Immunotherapy."},{"issue":"3","key":"624_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1586\/14760584.5.3.381","volume":"5","author":"SS Neelapu","year":"2006","unstructured":"Neelapu SS, Lee ST, Qin H, Cha SC, Woo AF, Kwak LW. Therapeutic lymphoma vaccines: importance of T-cell immunity. Expert Rev Vaccines. 2006;5(3):381\u201394.","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"624_CR7","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1158\/1078-0432.CCR-13-2283","volume":"20","author":"L Marconato","year":"2014","unstructured":"Marconato L, Frayssinet P, Rouquet N, Comazzi S, Leone VF, Laganga P, Rossi F, Vignoli M, Pezzoli L, Aresu L. Randomized, placebo-controlled, double-blinded chemoimmunotherapy clinical trial in a pet dog model of diffuse large B-cell lymphoma. Clin Cancer Res. 2014;20(3):668\u201377.","journal-title":"Clin Cancer Res"},{"issue":"39","key":"624_CR8","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.1016\/j.vaccine.2015.08.017","volume":"33","author":"L Marconato","year":"2015","unstructured":"Marconato L, Stefanello D, Sabattini S, Comazzi S, Riondato F, Laganga P, Frayssinet P, Pizzoni S, Rouquet N, Aresu L. Enhanced therapeutic effect of APAVAC immunotherapy in combination with dose-intense chemotherapy in dogs with advanced indolent B-cell lymphoma. Vaccine. 2015;33(39):5080\u20136.","journal-title":"Vaccine."},{"issue":"1","key":"624_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/0300985810379428","volume":"48","author":"V. E. Valli","year":"2010","unstructured":"Valli VE, San Myint M, Barthel A, Bienzle D, Caswell J, Colbatzky F, DurhamA, Ehrhart EJ, Johnson Y, Jones C, et al. classification of canine malignant lymphomas according to the World Health Organization criteria. Vet Pathol 2011; 48: 198\u2013211.","journal-title":"Veterinary Pathology"},{"issue":"1","key":"624_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1476-5829.2009.00200.x","volume":"8","author":"DM Vail","year":"2010","unstructured":"Vail DM, Michels GM, Khanna C, Selting KA. London CA; veterinary cooperative oncology group. Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a veterinary cooperative oncology group (VCOG) consensus document. Vet Comp Oncol. 2010;8(1):28\u201337.","journal-title":"Vet Comp Oncol"},{"issue":"2","key":"624_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.tvjl.2014.03.006","volume":"200","author":"L Aresu","year":"2014","unstructured":"Aresu L, Aric\u00f2 A, Ferraresso S, Martini V, Comazzi S, Riondato F, Giantin M, Dacasto M, Guadagnin E, Frayssinet P, et al. Minimal residual disease detection by flow cytometry and PARR in lymph node, peripheral blood and bone marrow, following treatment of dogs with diffuse large B-cell lymphoma. Vet J. 2014;200(2):318\u201324.","journal-title":"Vet J"},{"issue":"2","key":"624_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/vco.12453","volume":"17","author":"Carmit Chalfon","year":"2019","unstructured":"Chalfon C, Martini V, Comazzi S, Aresu L, Stefanello D, Riondato F, Ferrari R, Marconato L. Minimal residual disease in lymph nodes after achievement of complete remission predicts time to relapse in dogs with large B-cell lymphoma. Vet Comp Oncol. 2018 Dec 21. \n                    https:\/\/doi.org\/10.1111\/vco.12453\n                    \n                  .","journal-title":"Veterinary and Comparative Oncology"},{"issue":"4","key":"624_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/vco.283","volume":"14","author":"Veterinary cooperative oncology group - common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1","year":"2016","unstructured":"Veterinary cooperative oncology group - common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1. Vet Comp Oncol. 2016;14(4):417\u201346.","journal-title":"Vet Comp Oncol"},{"issue":"10","key":"624_CR14","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1158\/0008-5472.CAN-12-3366","volume":"73","author":"BM Andersen","year":"2013","unstructured":"Andersen BM, Pluhar GE, Seiler CE, Goulart MR, SantaCruz KS, Schutten MM, Meints JP, O'Sullivan MG, Bentley RT, Packer RA, et al. Vaccination for invasive canine meningioma induces in situ production of antibodies capable of antibody-dependent cell-mediated cytotoxicity. Cancer Res. 2013;73(10):2987\u201397.","journal-title":"Cancer Res"},{"issue":"4","key":"624_CR15","first-page":"1284","volume":"9","author":"PJ Bergman","year":"2003","unstructured":"Bergman PJ, McKnight J, Novosad A, Charney S, Farrelly J, Craft D, Wulderk M, Jeffers Y, Sadelain M, Hohenhaus AE, et al. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Clin Cancer Res. 2003;9(4):1284\u201390.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"624_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1476-5829.2007.00128.x","volume":"5","author":"MM Turek","year":"2007","unstructured":"Turek MM, Thamm DH, Mitzey A, Kurzman ID, Huelsmeyer MK, Dubielzig RR, Vail DM. Human granulocyte-macrophage colony-stimulating factor DNA cationic-lipid complexed autologous tumour cell vaccination in the treatment of canine B-cell multicentric lymphoma. Vet Comp Oncol. 2007;5(4):219\u201331.","journal-title":"Vet Comp Oncol"},{"issue":"8","key":"624_CR17","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/mt.2010.104","volume":"18","author":"D Peruzzi","year":"2010","unstructured":"Peruzzi D, Gavazza A, Mesiti G, Lubas G, Scarselli E, Conforti A, Bendtsen C, Ciliberto G, La Monica N, Aurisicchio L. A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma. Mol Ther. 2010;18(8):1559\u201367.","journal-title":"Mol Ther"},{"issue":"12","key":"624_CR18","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2460\/ajvr.72.12.1631","volume":"72","author":"DA Grosenbaugh","year":"2011","unstructured":"Grosenbaugh DA, Leard AT, Bergman PJ, Klein MK, Meleo K, Susaneck S, Hess PR, Jankowski MK, Jones PD, Leibman NF, et al. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor. Am J Vet Res. 2011;72(12):1631\u20138.","journal-title":"Am J Vet Res"},{"issue":"8","key":"624_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024167","volume":"6","author":"KU Sorenmo","year":"2011","unstructured":"Sorenmo KU, Krick E, Coughlin CM, Overley B, Gregor TP, Vonderheide RH, Mason NJ. CD40-activated B cell cancer vaccine improves second clinical remission and survival in privately owned dogs with non-Hodgkin's lymphoma. PLoS One. 2011;6(8):e24167.","journal-title":"PLoS One"},{"issue":"14","key":"624_CR20","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1158\/1078-0432.CCR-13-3042","volume":"20","author":"F Riccardo","year":"2014","unstructured":"Riccardo F, Iussich S, Maniscalco L, Lorda Mayayo S, La Rosa G, Arigoni M, De Maria R, Gattino F, Lanzardo S, et al. CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA. Clin Cancer Res. 2014;20(14):3753\u201362.","journal-title":"Clin Cancer Res"},{"issue":"17","key":"624_CR21","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1158\/1078-0432.CCR-16-0088","volume":"22","author":"NJ Mason","year":"2016","unstructured":"Mason NJ, Gnanandarajah JS, Engiles JB, Gray F, Laughlin D, Gaurnier-Hausser A, Wallecha A, Huebner M, Paterson Y. Immunotherapy with a HER2-targeting Listeria induces HER2-specific immunity and demonstrates potential therapeutic effects in a phase I trial in canine osteosarcoma. Clin Cancer Res. 2016;22(17):4380\u201390.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"624_CR22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/jvim.12603","volume":"29","author":"KL Wycislo","year":"2015","unstructured":"Wycislo KL, Fan TM. The immunotherapy of canine osteosarcoma: a historical and systematic review. J Vet Intern Med. 2015;29(3):759\u201369.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"624_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/vetsci2030150","volume":"2","author":"M Zandvliet","year":"2015","unstructured":"Zandvliet M, Teske E. Mechanisms of drug resistance in veterinary oncology- a review with an emphasis on canine lymphoma. Vet Sci. 2015;2(3):150\u201384.","journal-title":"Vet Sci"},{"issue":"2","key":"624_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1939-1676.2006.tb02864.x","volume":"20","author":"SE Lana","year":"2006","unstructured":"Lana SE, Jackson TL, Burnett RC, Morley PS, Avery AC. Utility of polymerase chain reaction for analysis of antigen receptor rearrangement in staging and predicting prognosis in dogs with lymphoma. J Vet Intern Med. 2006;20(2):329\u201334.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"624_CR25","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.tvjl.2013.05.003","volume":"197","author":"L Marconato","year":"2013","unstructured":"Marconato L, Martini V, Aresu L, Sampaolo M, Valentini F, Rinaldi V, Comazzi S. Assessment of bone marrow infiltration diagnosed by flow cytometry in canine large B cell lymphoma: prognostic significance and proposal of a cut-off value. Vet J. 2013;197(3):776\u201381.","journal-title":"Vet J"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-019-0624-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40425-019-0624-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-019-0624-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:44:28Z","timestamp":1601055868000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1186\/s40425-019-0624-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["624"],"URL":"https:\/\/doi.org\/10.1186\/s40425-019-0624-y","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,7]]},"assertion":[{"value":"14 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As this retrospective evaluation did not influence any therapeutic decision, approval by an Ethics Committee was not required. All the examined samples were collected for diagnostic purposes as part of routine standard care. Owners gave their written informed consent to the use of clinical data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NR and PF are employees of the company that had developed and commercializes APAVAC. There are no further competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}